Endothelial secretion of several fibrinolytic factors is dysregulated in response to inflammation in cardiovascular disease, including plasminogen activator inhibitor-1 (PAI-1), urokinase plasminogen activator (uPA), and tissue-type plasminogen activator (tPA) [26,27]. The gene discussed is PLAU; the disease is cardiovascular disorder.